Popular Content
Pharmacy Law





Pharmacists and Prescription Drug Schemes 4/19/2013

Two recent cases in Michigan involve pharmacists charged with running illegal prescription drug schemes.

Whistleblowing and Retaliatory Discharge 3/20/2013

Three cases involving at-will employment of pharmacists examine whether their terminations were legal.

Insider Trading and Clinical Trials 2/20/2013

The largest insider-trading case in history involves a doctor who provided results from an Alzheimer’s drug trial to a hedge fund.


Off-Label Promotion Is Free Speech 1/23/2013

Does the ban on off-label marketing of drugs violate a pharmaceutical sales representative’s freedom of speech?

Compounding: Problem or Pariah? 12/19/2012

The company at the center of the fungal meningitis outbreak was acting as a manufacturer and not as a traditional compounding pharmacy.


Emergency Contraception: Law & Ethics 11/20/2012

Illinois pharmacists are no longer required to dispense emergency contraception when their own religious beliefs are opposed to its use.


Recent DEA Developments 10/19/2012

E-prescribing of controlled substances and prescription misuse are among the many issues being addressed by the DEA.


Affordable Care Act (Mostly) Upheld 8/21/2012

Demands for pharmacist services under the ACA are likely to have a huge impact on future workforce needs.

The Controlled Substances Pendulum 7/18/2012

As gatekeepers of controlled substances, pharmacists must distinguish between legitimate and questionable prescriptions.

Pharmacy Fraud, Waste, and Abuse 6/20/2012

According to a government report, questionable Medicare Part D billing seems to be on the rise in community pharmacies.

DEA Continues Corporate Responsibility Drive 5/22/2012

Another chain-store pharmacy is being investigated for distributing “too much” oxycodone.

Corporate Social Responsibility: Justice Without Due Process? 4/23/2012

The DEA’s expectations for policing pharmacies and their patients who request controlled substances are unclear.

Off-Label Use of Alzheimer’s Drugs 3/20/2012

The quest for more effective treatments may lead to questionable off-label prescribing.


Duty to Warn With No Directions for Use 2/17/2012

It’s time to end the confusing practice of putting “Use as directed” on prescriptions.


The (Non) Law of Drug Shortages 1/20/2012

Many factors contribute to why reported drug shortages are at their highest levels in more than a decade. 

Free Speech, Drug Marketing, and Off-Label Use 12/20/2011

Does prohibiting off-label promotion of drugs violate commercial free speech?

FDA Tries to Compound the Compounding Rules 11/16/2011

The FDA has continually questioned the traditional compounding of veterinary drugs. 

Legal Consequences of Social Networking 10/19/2011

As health care professionals, pharmacists must be cautious when sharing information online. 

Brand-Name and Generic Drugs Not Equivalent in Malpractice Claims 9/20/2011

A recent Supreme Court ruling means that generic manufacturers cannot be held liable for inadequate warning labels. 

Last Words: Data Mining Is Legal 8/19/2011

The Supreme Court has ruled that state attempts to restrict this practice are unconstitutional. 
For more articles, please check our archives.
Advertisement